Literature DB >> 9286062

Mycoplasma infections of the human respiratory tract.

E Jacobs1.   

Abstract

Mycoplasma pneumoniae represents one of the common etiological agents causing interstitial pneumonia, but more often a long-lasting tracheobronchitis in children and also in adults. The incidence of Mycoplasma pneumoniae diseases varies considerably, major outbreaks being reported every 3 to 5 years. The pathomechanism of this agent is based on a unique, gliding motility, adhesion to respiratory epithelium cells and the induction of a pathological hyperstimulation of cellular response mechanisms of the host. Antigenic similarities between important functional sites of the adhesin of Mycoplasma pneumoniae and various host molecules might be one of the factors responsible for hindering the host-response mechanism and, moreover, failing to protect the host repeated colonization. These are indications of a near perfect adaptation of Mycoplasma pneumoniae to man, its only known host to date.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286062

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  13 in total

1.  The complete genome sequence of the murine respiratory pathogen Mycoplasma pulmonis.

Authors:  I Chambaud; R Heilig; S Ferris; V Barbe; D Samson; F Galisson; I Moszer; K Dybvig; H Wróblewski; A Viari; E P Rocha; A Blanchard
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

2.  In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae.

Authors:  Sven Halbedel; Claudine Hames; Jörg Stülke
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

3.  Multiple-mutation reaction: a method for simultaneous introduction of multiple mutations into the glpK gene of Mycoplasma pneumoniae.

Authors:  Claudine Hames; Sven Halbedel; Oliver Schilling; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

4.  Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples.

Authors:  Roger Dumke; Paul Christian Lück; Christoph Noppen; Christoph Schaefer; Heike von Baum; Reinhard Marre; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Expression of Mycoplasma proteins carrying an affinity tag in M. pneumoniae allows rapid purification and circumvents problems related to the aberrant genetic code.

Authors:  Sebastian R Schmidl; Claudine Hames; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2007-10-12       Impact factor: 4.792

6.  Probing in vivo promoter activities in Mycoplasma pneumoniae: a system for generation of single-copy reporter constructs.

Authors:  Sven Halbedel; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

7.  Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods.

Authors:  M P Layani-Milon; I Gras; M Valette; J Luciani; J Stagnara; M Aymard; B Lina
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  The phosphoproteome of the minimal bacterium Mycoplasma pneumoniae: analysis of the complete known Ser/Thr kinome suggests the existence of novel kinases.

Authors:  Sebastian R Schmidl; Katrin Gronau; Nico Pietack; Michael Hecker; Dörte Becher; Jörg Stülke
Journal:  Mol Cell Proteomics       Date:  2010-01-22       Impact factor: 5.911

9.  Frequent detection of Mycoplasma pneumoniae in Bell's palsy.

Authors:  C Völter; J Helms; B Weissbrich; P Rieckmann; M Abele-Horn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

10.  Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Authors:  Sueli B Damy; Maria L Higuchi; Jorge Timenetsky; Márcia M Reis; Suely P Palomino; Renata N Ikegami; Fabiana P Santos; Junko T Osaka; Luiz P Figueiredo
Journal:  BMC Microbiol       Date:  2009-09-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.